Linical Co (TSE:2183) EBITDA: 円-2,482 Mil (TTM As of Mar. 2026)


TSE:2183 Linical Co Ltd TSE:2183
48 GF Score
Price 円202.00
GF Value 円310.47
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Linical Co EBITDA?

Linical Co TSE:2183 -0.98% 48 EBITDA is 円-2,482 Mil as of Mar. 2026. GuruFocus rates TSE:2183 with a GF Score™ of 48/100 and a GF Value™ of 円310.47 (Possible Value Trap). The stock has 5 warning signs investors should review.

Linical Co's EBITDA for the six months ended in Mar. 2026 was 円-2,197 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円-2,482 Mil.

During the past 12 months, the average EBITDA Growth Rate of Linical Co was -7009.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Linical Co was 45.00% per year. The lowest was -71.10% per year. And the median was 12.40% per year.

Linical Co's EBITDA per Share for the six months ended in Mar. 2026 was 円-97.27. Its EBITDA per share for the trailing twelve months (TTM) ended in Mar. 2026 was 円-109.87.

During the past 12 months, the average EBITDA per Share Growth Rate of Linical Co was -7010.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Linical Co was 45.10% per year. The lowest was -96.30% per year. And the median was 13.80% per year.

Linical Co  (TSE:2183) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Linical Co EBITDA Related Terms


Linical Co EBITDA Historical Data

* Premium members only.

The historical data trend for Linical Co's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co EBITDA Chart

Linical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,486.70 1,891.47 1,196.14 35.91 -2,481.53

Linical Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 557.85 37.32 -1.41 -284.65 -2,196.89

TSE:2183 vs VRTX, REGN, ALNY: EBITDA Comparison

For the Biotechnology subindustry, Linical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Linical Co EV-to-EBITDA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Linical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Linical Co's EV-to-EBITDA falls into.


TSE:2183
48GF Score
Linical Co Ltd TSE:2183
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Linical Co's EBITDA for the fiscal year that ended in Mar. 2026 is calculated as

Linical Co's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Mar. 2026, Linical Co's EBITDA was 円-2,482 Mil.

Linical Co's EBITDA for the quarter that ended in Mar. 2026 is calculated as

Linical Co's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Mar. 2026, Linical Co's EBITDA was 円-2,197 Mil.

EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-2,482 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of 円-2,482 Mil mean?
Linical Co (TSE:2183) has a EBITDA of 円-2,482 Mil as of Mar. 2026. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Linical Co.
Is Linical Co's EBITDA too high?
Linical Co's current EBITDA is 円-2,482 Mil. Overall, Linical Co has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's EBITDA compare to VRTX and REGN?
Linical Co's EBITDA of 円-2,482 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Biotechnology company?
A good EBITDA depends on the Biotechnology industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Linical Co. Linical Co's current EBITDA is 円-2,482 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円310.47, compared to a current price of 円202.00 — trading 34.9% below its estimated fair value. The current EBITDA is 円-2,482 Mil. Linical Co's overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Linical Co (TSE:2183), the current EBITDA is 円-2,482 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円202.00 is trading 34.9% below its estimated GF Value™ of 円310.47. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

  • EBITDA: 円-2,482 Mil
  • GF Value™: 円310.47 vs. price of 円202.00 (34.9% below fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Linical Co Business Description

Address 1-6-1 Miyahara, 10th floor, Shin-Osaka Brick Building, Yodogawa-ku, Osaka, JPN, 532-0003
Linical Co Ltd is a pharmaceutical company.
48GF Score

Get the complete analysis for TSE:2183

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円202.00
Price
円310.47
GF Value